UCLA School of Medicine

Los Angeles, California 90095-3075

1 studies enrolling now · 64 studies all time

What they study most

AML, Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Acute Renal Allograft Rejection, Alzheimer's Disease, Astrocytoma, Autoimmune Diseases, B-Cell Lymphoma, BRAF Mutant Colorectal Cancer, Breast Cancer, Cadaveric Donor Renal Transplantation, Carcinoma, Renal Cell

Studies at this site

• To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313) — Stopped early
• Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04] — Running, not enrolling
• Enhancing Innate Anti-Viral Resistance Through A Community-Based Intervention - Generation Xchange — Enrolling by invitation
• A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands — Completed
• Prospective Huntington At Risk Observational Study — Completed
• A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis — Stopped early
• A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — Completed
• TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy — Completed
• Treatment for Endogenous Cushing's Syndrome — Completed
• PREMIUM Migraine Trial — Completed
• Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer. — Completed
• First in Patient Study for PF-06840003 in Malignant Gliomas — Stopped early
• Open Label Study to Evaluate Safety and Efficacy of 2 Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia — Completed
• Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence — Completed
• Sym004 in Combination With FOLFIRI in Metastatic Colorectal Cancer Patients — Stopped early
• A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer — Completed
• An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry) — Completed
• Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1 — Completed
• CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma — Completed
• A Pharmacokinetic Study of RO5185426 in Combination With a Drug Cocktail in Patients With Metastatic Melanoma — Completed
• Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS — Completed
• Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer — Completed
• Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter) — Completed
• A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma — Completed
• Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia — Stopped early
• A Trial of the Pharmacokinetics, Safety, and Tolerability of Subcutaneous Gamunex® in Primary Immunodeficiency — Completed
• An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients. — Completed
• A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell Carcinoma — Completed
• A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I) — Completed
• A Study to Evaluate PT-523 in Patients With Refractory Leukemia — Withdrawn before enrolling
• TH9507 in Patients With HIV-Associated Lipodystrophy — Completed
• Tiotropium (Spiriva) Rehabilitation Study — Completed
• Prevention Trial of Family Focused Treatment in Youth at Risk for Psychosis — Completed
• Bio-Seal Biopsy Track Plug for Reducing Pneumothorax Rates Post Lung Biopsy Procedure — Completed
• Safety, Effectiveness, and Tolerability of Ezetimibe Combined With Statins for the Treatment of High Cholesterol in HIV Infected Adults — Completed
• CIS001 Extension Study of Cyclosporine Inhalation Solution — Stopped early
• Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation — Completed
• A Study of HIV Levels During Pregnancy and After Childbirth — Completed
• Safety and Anti-Disease Activity of Oral Tosedostat (CHR-2797) in Elderly Subjects With Refractory or Relapsed AML — Completed
• Extension to Study of Effects of Pomegranate Extract on Rising PSA Levels After Primary Therapy for Prostate Cancer — Status unconfirmed
• Open-label Extension Study of the Effects of Pomegranate Extract on Rising PSA After Primary Therapy for Prostate Cancer — Status unconfirmed
• AEG35156 in Combination With High-dose Cytarabine and Idarubicin in AML Following Failure of a Single Standard Dose Cytarabine Based Frontline Induction Regimen — Stopped early
• Cooperative Huntington's Observational Research Trial — Status unconfirmed
• Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients — Completed
• Using Drug Levels in the Blood to Guide Therapy in HIV Infected Patients Taking a Protease Inhibitor — Completed
• Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis — Completed
• The Effect of Alendronate, Calcium, and Vitamin D on Bone Mineral Density in HIV Infected Patients — Completed
• YSPSL for Prevention of Ischemic Reperfusion Injury in Patients Undergoing Cadaveric Orthotopic Liver Transplantation — Status unconfirmed
• Volociximab in Combination With DTIC in Patients With Metastatic Melanoma Not Previously Treated With Chemotherapy — Completed
• VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma — Completed